Cancer lurks in shadow.
Let’s discover it early.
Every cancer patient needs this test.
The OncoDiscover® CTC Test can detect cancer earlier and faster than traditional tests.
01
Early Detection of Cancer.
Early diagnosis = Better prognosis
It is widely accepted that early detection of cancer is key to ensure a better outcome of cancer therapy for patients. But usually the earliest indication of cancer is due to symptoms (bleeding, lumps, non-healing wound etc) rather than the result of proactive testing. Since these symptoms are at many times improperly diagnosed or ignored, many patients are diagnosed with cancer only at a later stage.
This makes treatment and recovery difficult for the patient. Cancer metastasis accounts for 90% of cancer deaths in comparison to deaths due to primary tumor. Thus, it is critical to know at the earliest possible stage about presence or spread of cancer.
In a normal ‘healthy’ human being or in a person detected with possible cancer symptoms, the OncoDiscover® CTC Test can be used to identify presence of cancer and the extent of cancer metastasis. This will ensure that awareness of cancer presence is at the earliest possible stage and may result in better outcome during treatment.
02
Detection of Cancer Relapse
Conventional tests have limited sensitivity or are difficult to perform on a regular basis to track the recurrence of cancer.
It is widely accepted that early detection of cancer is key to ensure a better outcome of cancer therapy for patients. But usually the earliest indication of cancer is due to symptoms (bleeding, lumps, non-healing wound etc) rather than the result of proactive testing. Since these symptoms are at many times improperly diagnosed or ignored, many patients are diagnosed with cancer only at a later stage.
This makes treatment and recovery difficult for the patient. Cancer metastasis accounts for 90% of cancer deaths in comparison to deaths due to primary tumor. Thus, it is critical to know at the earliest possible stage about presence or spread of cancer.
In a normal ‘healthy’ human being or in a person detected with possible cancer symptoms, the OncoDiscover® CTC Test can be used to identify presence of cancer and the extent of cancer metastasis. This will ensure that awareness of cancer presence is at the earliest possible stage and may result in better outcome during treatment.
03
Monitoring of cancer therapy.
Many patients are intolerant to the PET/CT and cannot undergo the scan multiple times.
It is widely accepted that early detection of cancer is key to ensure a better outcome of cancer therapy for patients. But usually the earliest indication of cancer is due to symptoms (bleeding, lumps, non-healing wound etc) rather than the result of proactive testing. Since these symptoms are at many times improperly diagnosed or ignored, many patients are diagnosed with cancer only at a later stage.
This makes treatment and recovery difficult for the patient. Cancer metastasis accounts for 90% of cancer deaths in comparison to deaths due to primary tumor. Thus, it is critical to know at the earliest possible stage about presence or spread of cancer.
In a normal ‘healthy’ human being or in a person detected with possible cancer symptoms, the OncoDiscover® CTC Test can be used to identify presence of cancer and the extent of cancer metastasis. This will ensure that awareness of cancer presence is at the earliest possible stage and may result in better outcome during treatment.